A proof of concept study in allergic rhinitis, to evaluate the differential effects of doxazosin between single and chronic dosing on nasal airway calibre

Trial Profile

A proof of concept study in allergic rhinitis, to evaluate the differential effects of doxazosin between single and chronic dosing on nasal airway calibre

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Doxazosin (Primary)
  • Indications Allergic rhinitis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 11 Dec 2015 Status changed from discontinued to completed as reported by Clinicaltrials.gov.
    • 18 Jul 2015 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
    • 21 Sep 2013 Planned number of patients changed from 16 to 24 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top